UBS AM’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.73M | Sell |
272,660
-30,485
| -10% | -$641K | ﹤0.01% | 1649 |
|
2025
Q1 | $4.97M | Sell |
303,145
-20,141
| -6% | -$330K | ﹤0.01% | 1581 |
|
2024
Q4 | $8.31M | Buy |
323,286
+4,790
| +2% | +$123K | ﹤0.01% | 1338 |
|
2024
Q3 | $10.1M | Buy |
318,496
+6,219
| +2% | +$197K | ﹤0.01% | 1214 |
|
2024
Q2 | $11M | Buy |
312,277
+80,759
| +35% | +$2.84M | ﹤0.01% | 1091 |
|
2024
Q1 | $10.2M | Sell |
231,518
-42,583
| -16% | -$1.87M | ﹤0.01% | 986 |
|
2023
Q4 | $9.75M | Buy |
274,101
+3,710
| +1% | +$132K | ﹤0.01% | 992 |
|
2023
Q3 | $7.3M | Buy |
+270,391
| New | +$7.3M | ﹤0.01% | 1062 |
|
2023
Q1 | – | Sell |
-32,072
| Closed | -$583K | – | 2694 |
|
2022
Q4 | $583K | Buy |
32,072
+16,999
| +113% | +$309K | ﹤0.01% | 2117 |
|
2022
Q3 | $225K | Buy |
15,073
+4,973
| +49% | +$74.2K | ﹤0.01% | 2573 |
|
2022
Q2 | $139K | Hold |
10,100
| – | – | ﹤0.01% | 2619 |
|
2022
Q1 | $113K | Hold |
10,100
| – | – | ﹤0.01% | 2731 |
|
2021
Q4 | $239K | Buy |
+10,100
| New | +$239K | ﹤0.01% | 2732 |
|